A Reduced Postsynaptic Conductance Model of Complement-Associated Electrical Perturbation at the Neuromuscular Junction
Abstract The neuromuscular junction is a specialized bioelectrical interface governed by membrane conductances. In antibody-mediated disorders such as myasthenia gravis, complement-dependent injury disrupts this interface, but the electrical consequences of effective membrane-attack-complex-associated conductance remain incompletely defined. We developed a reduced, capacitance-based postsynaptic membrane model to assess how a time-dependent effective membrane-attack-complex-associated specific conductance changes membrane voltage and local specific input resistance. The model was formulated per unit membrane area and integrated with an adaptive Runge-Kutta method of orders four and five. A planar-bilayer C5b-9 conductance measurement and structural pore characterizations were used as conceptual priors; effective conductance, reversal potential, onset, duration, and repair were sensitivity variables. Under an illustrative parameter set, effective conductances of 1.5 and 5.0 millisiemens per square centimeter shifted the conductance-weighted steady voltage from negative 85 millivolts to approximately negative 28.8 and negative 16.8 millivolts and reduced local specific input resistance from 2.0 to 0.50 and 0.18 kiloohm square centimeters. A phenomenological 90 percent reduction in effective conductance produced partial, not complete, voltage recovery. A resting transmembrane voltage corresponds to a membrane-scale field on the order of ten million volts per meter under a uniform-field approximation. Whether complement-associated electrical perturbation changes the local field or conformational state of acetylcholine receptors remains untested. Accordingly, the model defines conditional receptor-coupling analyses and falsifiable electrophysiological and receptor-state experiments. Poloxamer 188 is considered only as a possible experimental comparator, not as a membrane attack complex sealant or therapeutic intervention for myasthenia gravis.
Authors
- Kevin Thorsen Baird (ORCID: https://orcid.org/0009-0001-7938-446X)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-16
- DOI
- https://doi.org/10.21203/rs.3.rs-11517246/v1
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- preprint